New drug that helps with Postpartum disorder, but is very expensive

The first approval of the only treatment in the United States specifically targeting postpartum depression is offering hope for many women each year who suffer from mental health disorder after giving birth.This new drug called brexanolone, but is marketed under the name Zulresso, was approved on March 19 by the U.S. Food and Drug Administration. Hopefully expected to become available to the public in late June. Unfortunately, the drug is very expensive and treatment is intensive. It’s administered in the hospital as a 60-hour intravenous drip, and a treatment runs between $20,000 and $35,000. But researchers say it could help 11.5 percent of U.S. new moms each year who experience postpartum depression. This could also help with the normal bonding between mothers and infants, leading to feeling hopeless, sad or overly anxious. I think this drug could rally help, but i also think that many new mothers will not be able to afford this option and will have to face the affects of postpartum disorder. I find it sad because they want help in feeling better but the only help they can receive would cost them thousands.  https://www.sciencenews.org/article/brexanolone-postpartum-depression